Smith & Nephew to Buy Plus Orthopedics

Smith & Nephew, a British maker of artificial hips, said Monday it agreed to buy Plus Orthopedics Holding, a private Swiss orthopedic company, for about 1.09 billion Swiss francs ($889 million; 617 million euros) in cash to boost its share of the orthopedic reconstruction market.

The British company will also assume debt of about $190 million (144.9 million euros).

Smith & Nephew expects the acquisition to boost earnings in 2008 and beyond. Plus Orthopedics Holding had gross assets of 436 million francs ($357 million; 269.3 million euros) at Dec. 31, 2006, the company said in a statement.

Plus develops a range of orthopedic implants, primarily hips and knees, and also small joint and shoulder products. The company posted revenue of 367 million francs ($300 million; 226.7 million euros). The acquisition will make Smith & Nephew the world's fourth-largest operator in the orthopedic reconstruction market with a market share of about 12%.

Smith & Nephew will finance the acquisition through bank borrowings.

The shares rose 2.5% to 631.00 pence ($12.20; 9.30 euros) on the London Stock Exchange


Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Former Federal Reserve Governor Randy Kroszner, and CNBC's Steve Liesman, discuss if today's GDP data will lead to the Fed adopting a faster exit policy and its focus on slack in the labor force.

  • Discussing today's GDP data and Fed policy, with Hank Smith, Haverford Investments; Jack Bouroudjian, Index Financial Partners; Anthony Chan, Chase; and CNBC's Rick Santelli.

  • The Federal Reserve is staying the course on bond tapering. CNBC's Steve Liesman discusses what the Fed may do moving forward considering today's strong GDP data.